Habib Dable

Habib Dable is an accomplished executive with extensive experience in the biopharmaceutical industry. Currently serving as an Independent Board Director at Day One Biopharmaceuticals and PepGen, Dable also holds a part-time position as a Venture Partner at RA Capital Management. Dable's previous roles include Board Chair and Independent Board Director at Aerovate Therapeutics, Independent Board Director at Blueprint Medicines and Albireo Pharma, as well as President and CEO of Acceleron Pharma. Dable's long tenure at Bayer, culminating in leadership positions such as President of U.S. Pharmaceuticals and EVP of Global Head Specialty Medicine, showcases a strong background in strategic planning and product management. Dable holds an MBA and a BBA from the University of New Brunswick and completed the Stanford Executive Program at Stanford University Graduate School of Business.